Increase cellular energy
The current fervor for GLP-1RAs in the capital markets as well as in the general public, especially in terms of weight reduction, is probably going to result in overuse, states Chun-Su Yuan, MD, PhD
"Adverse drug reactions"
Some of the most commonly used weight-loss peptides include: Semaglutide (GLP-1 agonist) - Helps control appetite, stabilizes blood sugar, and promotes steady fat loss Tirzepatide (GLP-1/GIP dual agonist) - Works on multiple metabolic pathways for even greater appetite suppression and energy balance When used under medical supervision, these peptides can support healthier, more sustainable weight-loss outcomes
Most plans require BMI criteria, documented weight loss efforts, prior authorization, and sometimes step therapy, which can affect both approval chances and out-of-pocket costs
*Correspondence: Yanfang Liu, [email protected] Wang, [email protected] Zhu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers